C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. 1997

W K Lagrand, and H W Niessen, and G J Wolbink, and L H Jaspars, and C A Visser, and F W Verheugt, and C J Meijer, and C E Hack
Department of Cardiology, Free University Hospital, Amsterdam, Netherlands. cardiol@azvu.nl

BACKGROUND Rises in circulating C-reactive protein (CRP), the prototypical acute-phase protein in humans, correlate with clinical outcome in patients with myocardial ischemia and infarction. We hypothesized that these correlations might reflect active participation of CRP in the local inflammatory response ensuing in the jeopardized myocardium because on binding to a ligand, CRP is able to activate the classic pathway of complement, and in addition, complement activation has been shown to occur locally in infarcted myocardium. RESULTS To verify our hypothesis, we investigated localization of CRP in relation to deposition of complement in tissue specimens of infarcted and healthy heart tissue obtained from 17 patients who had died after acute myocardial infarction. CRP was found to be deposited only in infarcted regions and not in normal-appearing areas of the myocardium, being colocalized with depositions of C4 and C3 activation fragments of the complement system. Deposition of CRP and complement in infarcted myocardium appeared to be time dependent, because it was found in all infarctions except for one of young age (< 12 hours old) and two of greater age (> 1 year old), whereas another tissue specimen of an infarct < 12 hours old showed only moderate but positive staining for both CRP and complement in comparison with older infarctions. CONCLUSIONS We conclude that in humans, CRP may localize in infarcted heart tissue and suggest that this acute-phase protein promotes local complement activation, and hence tissue damage, in acute myocardial infarction.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003167 Complement Activation The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES. Activation, Complement,Activations, Complement,Complement Activations
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

W K Lagrand, and H W Niessen, and G J Wolbink, and L H Jaspars, and C A Visser, and F W Verheugt, and C J Meijer, and C E Hack
January 2005, Immunopharmacology and immunotoxicology,
W K Lagrand, and H W Niessen, and G J Wolbink, and L H Jaspars, and C A Visser, and F W Verheugt, and C J Meijer, and C E Hack
January 2004, Circulation,
W K Lagrand, and H W Niessen, and G J Wolbink, and L H Jaspars, and C A Visser, and F W Verheugt, and C J Meijer, and C E Hack
August 2006, The New England journal of medicine,
W K Lagrand, and H W Niessen, and G J Wolbink, and L H Jaspars, and C A Visser, and F W Verheugt, and C J Meijer, and C E Hack
June 2004, Acta cardiologica,
W K Lagrand, and H W Niessen, and G J Wolbink, and L H Jaspars, and C A Visser, and F W Verheugt, and C J Meijer, and C E Hack
January 2023, Current pharmaceutical design,
W K Lagrand, and H W Niessen, and G J Wolbink, and L H Jaspars, and C A Visser, and F W Verheugt, and C J Meijer, and C E Hack
December 2003, The American journal of medicine,
W K Lagrand, and H W Niessen, and G J Wolbink, and L H Jaspars, and C A Visser, and F W Verheugt, and C J Meijer, and C E Hack
December 1999, The Journal of experimental medicine,
W K Lagrand, and H W Niessen, and G J Wolbink, and L H Jaspars, and C A Visser, and F W Verheugt, and C J Meijer, and C E Hack
June 2003, American heart journal,
W K Lagrand, and H W Niessen, and G J Wolbink, and L H Jaspars, and C A Visser, and F W Verheugt, and C J Meijer, and C E Hack
November 2012, Journal of cardiovascular medicine (Hagerstown, Md.),
W K Lagrand, and H W Niessen, and G J Wolbink, and L H Jaspars, and C A Visser, and F W Verheugt, and C J Meijer, and C E Hack
November 1997, European heart journal,
Copied contents to your clipboard!